Cole Pinnow
Fortune : 6 M $ au 31/07/2026
Fortune : 6 M $ au 31/07/2026
Cole Pinnow is currently Chief Commercial Officer at Cogent Biosciences, Inc. since 2024.
Formerly worked at Pfizer Inc. as Global Franchise Lead-Genitourinary.
Education includes undergraduate studies at St. Olaf College, graduate studies at Iowa State University, and an MBA from The University of Chicago Booth School of Business.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 13/04/2026 | 166 650 ( 0,1 % ) | 6 M $ | 31/07/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| COGENT BIOSCIENCES, INC. | Corporate Officer/Principal | 23/05/2024 |
| Sociétés | Poste | Fin |
|---|---|---|
| PFIZER INC. | Corporate Officer/Principal | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 5 |
|---|---|
Pfizer Inc.
Pfizer Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development, manufacturing, marketing, sale and distribution of biopharmaceutical products & ingredients | Health Technology |
Cogent Biosciences, Inc.
Cogent Biosciences, Inc. BiotechnologyHealth Technology Discovers and develops new cellular immunotherapies for cancer | Health Technology |
Iowa State University
Iowa State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
St. Olaf College
St. Olaf College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of Chicago Booth School of Business
The University of Chicago Booth School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national